Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial

Authors :: Xin Lu
Tao Tan
Danbo Wang
Lipai Chen
Beihua Kong
Lingying Wu
Yanling Feng
Jing Wang
Ge Lou
Hongying Yang
Ke Wang
Liang Song
Jianqing Zhu
Qi Zhou
Juan Dong
Ziling Liu
Yu Zhang
Jiaxin Yang
Yi Huang
Yunong Gao
Guiling Li
Ruifang An
Li Wang
Xiao-Jian Yan
Source :: Gynecologic Oncology. 162:S18-S19
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Obstetrics and Gynecology
chemistry.chemical_element
Subgroup analysis
chemistry
Maintenance therapy
Recurrent Ovarian Cancer
Partial response
Internal medicine
medicine
Platinum sensitive
In patient
Platinum
business

Tools